Amanda Cray

Amanda Cray

Investor Relations Contact bij FUSN PHAR
Health Technology
Consumer Services
Commercial Services

Profiel

Amanda Cray currently works as Senior Director-IR & Corporate Communications at Fusion Pharmaceuticals, Inc. and as Head-Investor Relations at Autolus Therapeutics Plc since 2024.
Former roles include Associate Director-IR & Corporate Communications at Aegerion Pharmaceuticals, Inc. from 2012 to 2019, Director-IR & Corporate Communications at Novelion Therapeutics, Inc. from 2016 to 2019, Senior Account Executive at LaVoie Strategic Communications Group, Inc., Associate at Sharon Merrill Associates, Inc., and Account Manager at Harron & Associates, Inc. Education includes graduate studies at Boston University and undergraduate studies at the University of New Hampshire.

Actieve functies van Amanda Cray

BedrijvenFunctieBegin
FUSN PHAR Investor Relations Contact -
AUTOLUS THERAPEUTICS PLC Investor Relations Contact 01-11-2024

Eerdere bekende functies van Amanda Cray

BedrijvenFunctieEinde
AEGERION PHARMACEUTICALS, INC. Investor Relations Contact 01-07-2019
NOVELION THERAPEUTICS INC. Investor Relations Contact 01-07-2019
Corporate Officer/Principal -
Harron & Associates, Inc.
Corporate Officer/Principal -
Corporate Officer/Principal -
Ervaring van Amanda Cray in detail bekijken

Opleiding van Amanda Cray

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

38

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit9

Health Technology

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Harron & Associates, Inc.

Health Technology

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Amanda Cray